Verax Biomedical gets FDA OK for platelet PGD test

The FDA has granted Verax Biomedical clearance to label and market its Platelet PGD test as a safety measure for blood platelet transfusions. The $30 assay, which is being marketed by Fenwal globally, takes less than 30 minutes to spot bacterial contamination in platelets prior to transfusion.

View Full Article in:

Mass High Tech (Boston) · Telegram & Gazette (Worcester, Mass.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ